News Breaks |
|
|
| January 11, 2013 |
| 11:00 EDT |  | REGN | FDA grants orphan status to Arcalyst in treatment of Mediterranean fever
Regeneron's (REGN) Arcalyst was designated for orphan drug status in the treatment of familial Mediterranean fever on Jan. 9, according to a posting on the FDA's website. Reference Link |
|
|
News For REGN From The Last 14 Days Check below for free stories on REGN the last two weeks. |
|
|
| May 20, 2013 |
| 19:01 EDT | | REGN | On The Fly: After Hours Movers
 Subscribe for More Information |
|
| 17:26 EDT | | REGN | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 17:20 EDT | | REGN | Regeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information |
|
| 07:28 EDT |  | REGN | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 17, 2013 |
| 10:07 EDT |  | REGN | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 07:16 EDT | | REGN | Regeneron initiated with a Neutral at UBS
Subscribe for More Information |
|
| 06:33 EDT | | REGN | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 15, 2013 |
| 05:39 EDT | | REGN | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information |
|
| May 14, 2013 |
| 07:34 EDT |  | REGN | Regeneron outlook positive, says RBC Capital
Subscribe for More Information |
|
| May 10, 2013 |
| 07:24 EDT | | REGN | Credit Suisse to host a conference
Subscribe for More Information |
| |
|
|
|
|
